Delivery Order SPE2DB22D3501-SPE2DB24FVY34
Award Date
6/11/24
Potential Completion Date
6/12/24
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The contract is a $3,461.50 Firm Fixed Price Delivery Order with a completion date of June 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order worth $17,247.01 for the supply of XELJANZ XR 11 MG TABLET. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 2, 2023. The contract is a firm fixed price type and does not have any set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $7,796.56 firm fixed price delivery order is for the supply of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical to provide...
The U.S. Defense Logistics Agency (DLA) awarded a $9,182.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,566,059,280 units of the prescription drug XELJANZ 5 MG TABLET with a completion date of October 10, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by DLA and other agencies to provide a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $4,415.81 and a completion date of February 4, 2025. It is a Firm Fixed Price Delivery Order contract for the supply of the pharmaceutical product XELJANZ XR 11 MG TABLET, which is used for various medical treatments. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,419.92, is for the supply of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The delivery order has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is a $4,325.58 firm fixed price delivery order (SPE2DX15D3504|SPE2DX24F08Y4) from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,565,266,579 XELJANZ XR 11 MG TABLET UU 30S. The award has an ultimate completion date of July 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $13,086.77 firm fixed price delivery order contract to provide XELJANZ 5 MG TABLET UU 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the prescription medication XELJANZ XR 11 MG TABLET. The $8,170.84 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $91,750.91. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2023 and is a firm fixed price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...